CME Group to launch single stock futures on 50+ top U.S. stocks

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

CME Group announced the upcoming launch of Single Stock futures on over 50 top U.S. stocks on July 27, pending regulatory approval. The initiative includes 55 larger-sized and 22 Micro-sized contracts designed to offer enhanced flexibility for managing equity exposure.

powered bylight_fuzz_icon
44381678

*this image is generated using AI for illustrative purposes only.

CME Group announced it will launch Single Stock futures on more than 50 top U.S. stocks on July 27, pending completion of all regulatory review and processes. The new offering aims to provide market participants with additional flexibility to manage their equity exposure through 55 larger-sized and 22 Micro-sized futures contracts.

Contract Details

The launch encompasses a total of 77 futures contracts, divided into two categories to cater to different trading needs:

Contract Type Number of Contracts
Larger-sized 55
Micro-sized 22

Regulatory Status

The rollout is subject to the completion of all necessary regulatory reviews and processes. CME Group, recognized as the world's leading derivatives marketplace, is proceeding with the launch to expand its equity derivatives product suite.

How will the introduction of these Single Stock futures impact liquidity in the underlying cash equity markets?

What competitive response can we expect from other derivatives exchanges like CBOE or ICE?

Will the new contracts attract significant institutional interest or primarily retail traders?

like20
dislike

CME sues CFTC over Kalshi perpetual futures approval

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

CME Group Inc. sued the CFTC over its approval of Kalshi's perpetual futures, citing competitive injury. Kalshi's crypto-tied products reached $8.5 billion in volume, while shares of Cboe, ICE, and Nasdaq fell. Coinbase has embraced the sector, recording over $211 billion in notional volume on similar contracts.

powered bylight_fuzz_icon
43780384

*this image is generated using AI for illustrative purposes only.

CME Group Inc. filed a lawsuit against the Commodity Futures Trading Commission last week regarding the regulator's decision to permit prediction market Kalshi to list perpetual futures. The lawsuit alleges the authorization violates federal law and has caused "textbook competitive injury" to the established exchange operator. This legal challenge highlights the growing tension between traditional financial infrastructure and emerging prediction markets offering high-leverage derivatives.

Kalshi's crypto-tied perpetual futures, or "perps," cleared $8.5 billion in volume within weeks of their launch, according to the Wall Street Journal. This rapid adoption has coincided with a decline in the share prices of incumbent exchanges. CME's Class A shares have dropped 12% since the CFTC's late-May approval. Other major exchanges have also experienced losses, reflecting market concerns about the competitive landscape.

Incumbent Exchange Performance

The following table illustrates the share price performance of major exchanges following the CFTC's approval of Kalshi's perpetual futures:

Company Ticker Exchange Share Decline
Cboe Global Markets CBOE BATS 26%
CME Group Inc. CME NASDAQ 12%
Intercontinental Exchange ICE NYSE 11%
Nasdaq Inc. NDAQ NASDAQ 9%

Mechanics and Market Risks

Perpetual futures differ from traditional futures as they never expire and allow traders to utilize significant leverage. CME CEO Terry Duffy warned at a Piper Sandler conference that traders lacking a deep understanding of these products risk getting "blown out." Traditional futures rely on margin calls where brokers request additional collateral, whereas perps utilize auto-liquidation. This mechanism sells positions automatically during sharp price drops to protect the platform, a feature that can fuel cascading selloffs. One surprise tariff announcement reportedly erased more than $19 billion in leveraged positions.

Kalshi CEO Tarek Mansour countered concerns about excessive risk, stating the platform offers leverage around six times, comparable to traditional futures. He attributed the pushback from established players to increased competition rather than product safety. "The incumbents don't like them because now there's competition," Mansour reportedly said.

Strategic Responses and Future Outlook

Wall Street remains divided on how to respond to the rise of perpetual futures. While CME has opted for litigation, other incumbents are considering adaptation. Cboe is reportedly weighing converting its continuous crypto futures into true perps, and Intercontinental Exchange indicated it would launch its own products if institutional clients demand them. Coinbase Global Inc. has already moved into this space, granting U.S. customers access to perpetual-style futures in July 2025, capped at 10x leverage on crypto. The company has also expanded its global lineup of perps tied to stock indexes, including AI, China, and defense names, with up to 20x leverage on ETF products. Coinbase reported logging over $211 billion in notional volume on perp-style contracts since that launch.

How will the outcome of CME's lawsuit against the CFTC shape the regulatory framework for other prediction markets seeking to launch high-leverage derivatives?

Will the competitive pressure from Kalshi force traditional exchanges like Cboe and ICE to accelerate their own perpetual futures product launches?

What systemic risks could the auto-liquidation mechanisms of perpetual futures pose to broader market stability during periods of extreme volatility?

like17
dislike

More News on CME Group Inc